GSI Creos Q1 FY2027 Earnings Analysis: Record-High Q1 Performance Driven by Mid-Term Plan Execution and Robust Shareholder Returns

Introduction

GSI Creos Corporation (TSE Prime: 8101) has released its financial results for the first quarter of the fiscal year ending March 31, 2027. As a business creation trading company centered on "Textiles" and "Industrial Products," the company is expanding globally and pursuing a long-term growth trajectory leading up to its 100th anniversary of founding (2027) and 100th anniversary of incorporation (2031).

This report provides an objective analysis based on disclosed materials, covering the factors behind the record-high Q1 performance, detailed segment trends, the progress of the mid-term management plan "GSI CONNECT Phase 2," and the shareholder return policy anchored by progressive dividends.

---

1. Q1 FY2027 Earnings Highlights

In the first quarter of FY2027, the company achieved year-on-year growth in both revenue and all profit categories, marking the highest performance for a first quarter on record .

As shown in the slide above, the operating results for the first quarter are as follows:

• Net Sales : 39.597 billion yen ( +4.8% YoY / +1.795 billion yen)
• Operating Profit : 996 million yen ( +10.9% YoY / +97 million yen)
• Operating Profit Margin : 2.5% ( +0.1pt YoY)
• Ordinary Profit : 1.121 billion yen ( +4.4% YoY / +46 million yen)
• Profit Attributable to Owners of Parent : 932 million yen ( +6.3% YoY / +54 million yen)

Against the full-year forecasts announced at the beginning of the period (May 15, 2026), the progress rate for net sales stands at 21.3% . However, operating profit reached 26.2% , ordinary profit 29.5% , and net profit 35.9% , indicating a solid start that exceeds the standard benchmark (25%).

---

2. Detailed Segment Analysis

The company's business is broadly divided into the core "Textile Business" and the "Industrial Products Business," which is positioned as a growth driver. The status of each business in the first quarter is as follows:

(1) Textile Business: Driving Significant Profit Growth

• Net Sales : 31.416 billion yen ( +4.8% YoY)
• Operating Profit : 648 million yen ( +43.5% YoY)
• Sales Composition : 79.3% / Operating Profit Composition : 57.0%

Breakdown and factors by sub-segment:

• Fiber : Net sales of 21.039 billion yen (-2.9% YoY), operating profit of 116 million yen ( +1,260.4% YoY). While transactions for functional yarns and fabrics for innerwear fell short of the previous year, they remained steady. The significant profit increase was driven by the absence of the allowance for doubtful accounts recorded in the same period last year.
• Outerwear : Net sales of 7.394 billion yen ( +34.0% YoY), operating profit of 412 million yen ( +31.7% YoY). Growth was driven by steady fabric sales to Europe and the US, as well as increased transactions for the proprietary "Soalon" triacetate fiber.
• Innerwear : Net sales of 2.981 billion yen ( +7.4% YoY), operating profit of 119 million yen (-8.1% YoY). Despite steady performance in mid-summer products, profit declined due to rising raw material costs and decreased demand in certain product categories, particularly lingerie.

(2) Industrial Products Business: Growth in Advanced Fields and Reactionary Decline

• Net Sales : 8.181 billion yen ( +4.4% YoY)
• Operating Profit : 489 million yen (-11.1% YoY)
• Sales Composition : 20.7% / Operating Profit Composition : 43.0%

Trends by sub-segment:

• Semiconductor : Net sales of 1.336 billion yen ( +18.7% YoY), operating profit of -1 million yen (improved from -13 million yen in the same period last year). Despite the lingering impact of US export restrictions on semiconductors to China, transactions for Chinese-made wafers remained steady.
• Chemical : Net sales of 4.487 billion yen ( +24.7% YoY), operating profit of 328 million yen ( +43.8% YoY). Export transactions for paint raw materials were strong, and profit increased due to price revisions for resins and films amid concerns over crude oil supply, as well as an increase in advance orders.
• Hobby & Life : Net sales of 1.376 billion yen ( +6.7% YoY), operating profit of 175 million yen ( +37.7% YoY). Growth was driven by sales of hobby-related products (e.g., "Mr. HOBBY") in China and Western markets, as well as an increase in cosmetic raw material transactions for the West.
• Machinery & Equipment : Net sales of 982 million yen (-46.1% YoY), operating profit of -12 million yen (compared to a profit of 208 million yen in the same period last year). While physics and chemistry-related equipment performed well, there was a significant decline in revenue and profit due to the reactionary effect of a large-scale composite material equipment project recorded in the previous year.

---

3. Global Expansion and Overseas Sales Ratio

The company maintains a robust global network with 9 domestic locations and 27 overseas locations (2 in Europe, 18 in Asia, 5 in North America, 2 in South America).

• Overseas Sales : 24.593 billion yen ( +1.4% YoY)
• Overseas Sales Ratio : 62.1% (maintaining a high level of over 60%)

By region, Asia accounts for 55.6% (mainly China and Hong Kong), Europe and others for 4.1%, and the Americas for 2.4%. The company is expanding value-added offerings to Western markets while maintaining its focus on the Asian region.

---

4. Mid-Term Management Plan "GSI CONNECT Phase 2" and Long-Term Vision

The company has set long-term vision targets for the fiscal year ending March 2032 (the 100th anniversary) and goals for the current mid-term management plan, "GSI CONNECT Phase 2."

Performance trends and targets under the mid-term plan are as follows:

• FY2026 (Year 1 of Plan - Actual) : Net Sales 188.677 billion yen, Operating Profit 3.605 billion yen, Net Profit 2.544 billion yen, ROE 8.2%
• FY2027 (Year 2 of Plan - Forecast) : Net Sales 186 billion yen, Operating Profit 3.8 billion yen, Net Profit 2.6 billion yen (projected record high)
• FY2028 (Final Year of Plan - Initial Target) : Net Sales 177 billion yen, Operating Profit 4 billion yen, Net Profit 3 billion yen, ROE >10%
• 2031 Vision (FY2032 - Long-term Goal) : Net Sales 200 billion yen, Net Profit 4 billion yen, Market Cap >50 billion yen

The company is pursuing improved profitability and capital efficiency by leveraging R&D functions, such as the proprietary "Triacetate (Soalon)" material, advanced chemical fields, and the Nanocarbon Development Center, which integrate manufacturer functions into its trading company operations.

---

5. Full-Year FY2027 Forecast and Business Environment

The full-year consolidated earnings forecast remains unchanged from the initial plan.

• Net Sales : 186 billion yen (-1.4% YoY)
• Operating Profit : 3.8 billion yen ( +5.4% YoY)
• Ordinary Profit : 3.8 billion yen (-3.2% YoY)
• Profit Attributable to Owners of Parent : 2.6 billion yen ( +2.2% YoY)

Despite uncertainties in the external environment, such as Middle Eastern tensions, energy price fluctuations, and supply shortage concerns, the company aims to achieve a record-high profit attributable to owners of the parent by focusing on its proprietary triacetate fiber business and chemical business.

---

6. Shareholder Return Policy and Benefits

The company implements a clear and proactive shareholder return policy based on management that is conscious of the cost of capital.

(1) Dividend Policy and Forecast

• Basic Policy : Maintains a "Dividend Payout Ratio of 50% or higher" and a "Progressive Dividend (minimum 100 yen per share)."
• FY2027 Dividend Forecast : Annual (year-end) 106.0 yen per share (Dividend Payout Ratio 50.0% ).
• Consecutive Dividend Increases : If the current plan is achieved, it will mark the 11th consecutive year of dividend increases .

(2) Shareholder Benefit Program

Shareholders who hold at least 100 shares for one year or more as of the end of September each year receive an original QUO card based on the number of shares and holding period (100-300 shares: 1-3 years 1,000 yen / 3+ years 2,000 yen; 300+ shares: 1-3 years 2,000 yen / 3+ years 3,000 yen).

---

7. New Business Creation and ESG Initiatives

As part of its new business development, the company operates "GSI Creos Memorial Clinic" in Brazil, where the number of dialysis patients is increasing, in partnership with a local company. The 5th location was opened in April 2026. Beyond supplying dialysis equipment and consumables, the company aims to expand its healthcare business in South America and deepen its ESG management through clinic operations. Other initiatives include Organic Photovoltaics (OPV) and strategic HR projects (GROW Project) to drive future business creation.

---

Summary

GSI Creos' Q1 FY2027 results marked a record-high performance for a first quarter, driven by the growth of proprietary products and adaptation to the business environment. The company expects to reach a record-high net profit for the full year and is steadily advancing measures to achieve the goals of its mid-term management plan, "GSI CONNECT Phase 2." With a robust shareholder return stance based on a progressive dividend policy (payout ratio of 50%+, 100 yen floor), the company continues its efforts to enhance corporate value as a business creation trading company.